The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes

Fineman, M.S., Koda, J.E., Shen, L.Z., Strobel, S.A., Maggs, D.G., Weyer, C., Kolterman, O.G.·2002·Metabolism
DOI 10.1053/meta.2002.32022

Cited by (129)

Items 101–129 of 129

  1. Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight
    Simone Anna Melander, Anna Thorsø Larsen, M.A. Karsdal, Kim Henriksen · 2024 · British Journal of Pharmacology
  2. Potential Protective Function of Aβ42 Monomer on Tauopathies
    Amber L. H. Gray, Victoria Norman, Damilola S. Oluwatoba, Rebecca A. Prosser, Thanh D. Do · 2023 · Journal of the American Society for Mass Spectrometry
  3. Non-Insulin Treatments for Diabetes
    Eugenio Angueira-Serrano · 2013 · American Journal of Therapeutics
  4. Biosynthesis, Secretion, and Action of Glucagon
    Pierre J. Lefèbvre · 2003
  5. Pramlintide: profile of an amylin analog
    Harold E. Lebovitz · 2012 · Expert Review of Endocrinology & Metabolism
  6. Adjunct Therapies In Type 1 Diabetes
    Paresh Dandona, Nitesh D Kuhadiya, Husam Ghanim, Ajay Chaudhuri · 2016 · Endocrine Practice
  7. Use of continuous glucose monitoring to introduce adjunctive pramlintide therapy in a patient with type 1 diabetes: A case study
    Tomas C. Walker · 2011 · Journal of the American Academy of Nurse Practitioners
  8. Antidiabetic Therapy in End‐Stage Renal Disease
    Suzanne M. Boyle, Barbara F. Simon, SIDNEY M. KOBRIN · 2015 · Seminars in Dialysis
  9. Physiological and Pathophysiological Control of Glucagon Secretion by Pancreatic α-Cells
    Patrick Gilon, Rui Cheng, Bao Khanh Lai, Heeyoung Chae, Ana Gómez-Ruiz · 2014 · Springer eBooks
  10. Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes
    FNU RUCHI, Michele Schiavon, Akhilesh Pandey, Chiara Dalla Man, Claudio Cobelli, Rita Basu, Ananda Basu · 2025 · Diabetes
  11. Emerging Insights into the Liver–Pancreas Axis: A Central Hub in the Pathogenesis of Diabetes and Metabolic Diseases
    Hengqian Dai, Z Zhang · 2026 · Biomolecules
  12. A Review of Pramlintide in the Management of Diabetes
    Caroline Messer, Dina Green · 2009 · Clinical Medicine Therapeutics
  13. New treatments of diabetes: The β-amylin agonists
    Harold E. Lebovitz · 2008 · Annales d Endocrinologie
  14. Non‐Insulin Parenteral Therapies
    Jens Juul Holst, Sten Madsbad, Ole Schmitz · 2010 · Wiley eBooks
  15. Considering Pramlintide Therapy for Postprandial Blood Glucose Control
    Belinda P. Childs, Nicole C. Kesty, ERIC J. KLEIN, Richard R. Rubin, Allison Wick · 2007 · Diabetes Spectrum
  16. Amylin: A Multi‐Functional Pancreatic Hormone—A Review
    Christelle Le Foll, Thomas A. Lutz · 2026 · Diabetes Obesity and Metabolism
  17. Cytotoxic Mechanisms of Islet Amyloid Polypeptide in the Pathogenesis of Type-2 Diabetes Mellitus (T2DM)
    Theri Leica Degaki, Dahabada H. J. Lopes, Mari Cleide Sogayar · 2011 · Springer eBooks
  18. Of Mice and Men: Translational Research on Amylin Agonism
    Jonathan David Roth, Christine M. Mack, James L. Trevaskis, David G. Parkes · 2011
  19. Islet Amyloid Polypeptide/GLP‐1/Exendin
    Laurie L. Baggio, Daniel J. Drucker · 2003
  20. Characterization of Cardiovascular Outcomes in a Type 2 Diabetes Glucose Supply and Insulin Demand Model
    Scott V. Monte, Jerome J. Schentag, Martin H. Adelman, Joseph A. Paladino · 2010 · Journal of Diabetes Science and Technology
  21. Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
    Sity Aishah Mansur · 2015 · UTHM Institutional Repository (Universiti Tun Hussein Onn Malaysia)
  22. Postprandial Glucose in Diabetes: Time for Action
    Mohsen Saleh Eledrisi · 2009 · Southern Medical Journal
  23. Non‐Insulin Parenteral Therapies
    Tina Vilsbøll, Mikkel Christensen, Tina Jorsal, Filip Krag Knop · 2016
  24. Pramlintide Acetate
    Dennis J. Cada, Terri L. Levien, Danial E. Baker · 2005 · Hospital Pharmacy
  25. Weight Loss in Diabetes: Pharmacological Management and Other Strategies
    Maria Isabel Gomez Coral · 2023 · Current Research in Diabetes & Obesity Journal
  26. Non‐insulin Parenteral Therapies
    Tina Vilsbøll, Mikkel Christensen, Andreas Andersen, Filip Krag Knop · 2024 · Wiley eBooks
  27. Contributions to glucagon and pramlintide pharmacokinetics and pharmacodynamics modeling for multi-hormone artificial pancreas systems
    Clara Furió-Novejarque · 2024
  28. Glycemic management in adults with type 1 diabetes
    Chrysi C. Koliaki, Stavros Liatis · 2026 · Elsevier eBooks
  29. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Richard I. G. Holt, J. Hans DeVries, Amy Hess Fischl, Irl B. Hirsch, Marian Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy Pettus, Éric Renard et al. · 2026 · Diabetologia